Craig - Joe

New York Marathon 2024

Fundraising for Cure Leukaemia
£4,000
raised of £2,000 target
Event: New York City Marathon 2024, on 3 November 2024
New York Marathon Team
Campaign by Cure Leukaemia (RCN 1100154)
Cure Leukaemia biggest team EVER of inspiring runners have COMPLETED the New York Marathon and raised vital donations to fund a dedicated Cure Leukaemia Research Nurses to enable clinical trials for blood cancer patients.

Story

On Sunday 3rd November, Craig and Joe will run for Team Cure Leukaemia in the New York Marathon!

We will be running/jogging/walking/crawling this Marathon in support of little Willow, Craig’s daughter who was diagnosed with Leukaemia at just 3 years old, and is currently battling her way through gruelling treatment.

Over 26.2 miles, I will run across the streets of New York on behalf of blood cancer patients across the world - with all funds raised helping the prospects of blood cancer patients, by funding more nurses and running more clinical trials through the Trials Acceleration Programme - so thank you for your generous donations!

Share this story

Help Craig - Joe

Sharing this page with your friends could help raise up to 3x more in donations

You can also help by sharing this link on

About the campaign

Cure Leukaemia biggest team EVER of inspiring runners have COMPLETED the New York Marathon and raised vital donations to fund a dedicated Cure Leukaemia Research Nurses to enable clinical trials for blood cancer patients.

About the charity

Cure Leukaemia

Verified by JustGiving

RCN 1100154
Cure Leukaemia fund research nurses at 15 hospitals across the UK. These roles form the Trials Acceleration Programme (TAP) network giving patients, from a catchment area of 30m, access to potentially life-saving treatments through clinical trials, with plans to fund a paediatric network on the way.

Donation summary

Total raised
£3,999.21
+ £599.50 Gift Aid
Online donations
£2,999.21
Offline donations
£1,000.00

* Charities pay a small fee for our service. Find out how much it is and what we do for it.